Differences in survival between patients with sarcomatoid carcinoma, carcinosarcoma and transitional cell carcinoma of the bladder.

被引：0
|
作者：
Black, Peter C.
Wright, Jonathan L.
Brown, Gordon A.
Gomez, Jose A.
Porter, Michael P.
Kamat, Ashish M.
Dinney, Colin P. N.
Lin, Daniel W.
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)31835-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：546 / 546
页数：1
相关论文
共 50 条
  • [21] Primary small cell carcinoma of the bladder.
    Tiguert, R
    Ravery, V
    Gheiler, EL
    Grignon, DJ
    Gudziak, MR
    Wood, DP
    Pontes, JE
    PROGRES EN UROLOGIE, 1999, 9 (02): : 256 - 260
  • [22] Survival of transitional cell carcinoma of the bladder for Japanese patients residing in the United States
    Kunbaz, Ahmad
    Saad, Anas M.
    Gad, Mohamed M.
    Obaid, Mariam A.
    Salahia, Sami
    Al-Husseini, Muneer J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [23] Amplification/overexpression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
    de Pinieux, G
    Vincent-Salomon, A
    Couturier, J
    Beuzeboc, P
    Vicillefond, A
    Sastro-Gerau, X
    LABORATORY INVESTIGATION, 2001, 81 (01) : 106A - 106A
  • [24] Amplification/overexpression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
    de Pinieux, G
    Vincent-Salomon, A
    Couturier, J
    Beuzeboc, P
    Vieillefond, A
    Sastro-Garau, X
    MODERN PATHOLOGY, 2001, 14 (01) : 106A - 106A
  • [25] Prognostic significance of topoisomerase II alpha overexpression in transitional cell carcinoma of the urinary bladder.
    Graber, MW
    Abrahams, HM
    Sheehan, CE
    Fisher, HAG
    Kaufman, RP
    Ross, JS
    LABORATORY INVESTIGATION, 1999, 79 (01) : 96A - 96A
  • [26] The impact of marital status on the survival of transitional cell carcinoma of the bladder
    Saad, Anas M.
    Baidoun, Firas
    Gad, Mohamed M.
    Ruhban, Inas A.
    Jazieh, Khalid
    Al-Husseini, Muneer J.
    Ornstein, Moshe Chaim
    Rini, Brian I.
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [27] Complement Factor H or a related protein is produced by bladder tumors and is a marker for transitional cell carcinoma of the bladder.
    Kinders, RJ
    Kinders, R
    Enfield, DL
    Hass, GM
    CLINICAL CHEMISTRY, 1998, 44 : A38 - A38
  • [28] Survival after radical treatment for transitional cell carcinoma of the bladder
    Dæhlin, L
    Haukaas, S
    Maartmann-Moe, H
    Medby, PC
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1999, 25 (01): : 66 - 70
  • [29] Safety and tolerability of oral halofuginone hydrobromide in refractory recurrent transitional cell carcinoma of the bladder.
    Nativ, O
    Thorpe, A
    Laufer, M
    Matzkin, H
    Salzberg, M
    Yarkoni, S
    Dezube, B
    Harris, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 445S - 445S
  • [30] Patched gene (PTC) mutations are present yet rare in transitional cell carcinoma of the bladder.
    McGarvey, TW
    Maruta, Y
    Tomaszewski, JE
    Linnenbach, AJ
    Malkowicz, SB
    JOURNAL OF UROLOGY, 1998, 159 (05): : 280 - 280
12345